GGrantIndex
← Leaderboards

Jeffrey L Neul

Baylor College Of Medicine

$10,916,278
Attributed
$19,061,619
Total exposure
14
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,910,215 · 17

By mechanism

U54$13,593,276 · 8
P50$10,372,605 · 3
R01$4,712,124 · 2
R61$2,464,143 · 1
R21$928,127 · 2
K08$839,940 · 1

Most similar at Baylor College Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Intellectual Functioning Disability

Research focus

Intellectual Functioning DisabilityResearch PersonnelServicesAffectFundingResourcesMental Retardation And Developmental Disabilities Research CentersTechnologyBehavioralTrainingTherapy DevelopmentNeurodevelopmental DisorderMouse ModelInsightDiagnosisGeneticBaseCollaborationsAnimalsNeuronsBrainMissionGenesPhenotype

Grant awards (77)

Core A: Administrative Core$1,220,356
P50 · FY2025 · HD · contact PI
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt$1,220,356
P50 · FY2025 · HD · contact PI
Development of Translatable Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome$701,399
R61 · FY2025 · NS
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt$1,358,025
P50 · FY2024 · HD · contact PI
Development of Translatable Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome$821,000
R61 · FY2024 · NS
Core A: Administrative Core$218,638
P50 · FY2024 · HD · contact PI
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt$1,358,023
P50 · FY2023 · HD · contact PI
Development of Translatable Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome$941,744
R61 · FY2023 · NS
Core A: Administrative Core$224,905
P50 · FY2023 · HD · contact PI
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt$1,358,023
P50 · FY2022 · HD · contact PI
Core A: Administrative Core$224,905
P50 · FY2022 · HD · contact PI
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt$1,364,066
P50 · FY2021 · HD · contact PI
Core A: Administrative Core$225,007
P50 · FY2021 · HD · contact PI
Development of a reliable, valid, and sensitive outcome measure in Rett syndrome$219,524
R21 · FY2021 · HD · contact PI
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt$1,387,605
P50 · FY2020 · HD · contact PI
Neurobehavioral and biochemical outcome measures in Rett syndrome rodent models$564,840
R01 · FY2020 · HD
Development of a reliable, valid, and sensitive outcome measure in Rett syndrome$275,091
R21 · FY2020 · HD · contact PI
Core A: Administrative Core$212,696
P50 · FY2020 · HD · contact PI
Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt University$1,299,999
U54 · FY2019 · HD · contact PI
Neurobehavioral and biochemical outcome measures in Rett syndrome rodent models$579,472
R01 · FY2019 · HD
Neurovisualization$352,497
U54 · FY2019 · HD
Neuroconnectivity Core$235,950
U54 · FY2019 · HD
Clinical Translational$231,388
U54 · FY2019 · HD
Administrative Core$202,464
U54 · FY2019 · HD
Steps towards a paternal gene activation therapy for Angelman syndrome$163,388
U54 · FY2019 · HD
Neurobehavioral$112,776
U54 · FY2019 · HD
Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt University$1,299,999
U54 · FY2018 · HD · contact PI
Neurobehavioral and biochemical outcome measures in Rett syndrome rodent models$609,125
R01 · FY2018 · HD
Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt$604,038
U54 · FY2018 · HD · contact PI
Neurovisualization$340,835
U54 · FY2018 · HD
Clinical Translational$245,549
U54 · FY2018 · HD
Steps towards a paternal gene activation therapy for Angelman syndrome$236,024
U54 · FY2018 · HD
Neuroconnectivity Core$235,950
U54 · FY2018 · HD
Administrative Core$131,044
U54 · FY2018 · HD
Neurobehavioral$109,061
U54 · FY2018 · HD
Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt University$1,299,999
U54 · FY2017 · HD · contact PI
Neurobehavioral and biochemical outcome measures in Rett syndrome rodent models$629,219
R01 · FY2017 · HD
Neurovisualization$340,835
U54 · FY2017 · HD
Clinical Translational$245,549
U54 · FY2017 · HD
Steps towards a paternal gene activation therapy for Angelman syndrome$236,024
U54 · FY2017 · HD
Neuroconnectivity Core$235,950
U54 · FY2017 · HD
Administrative Core$131,044
U54 · FY2017 · HD
Neurobehavioral$109,061
U54 · FY2017 · HD
Neurobehavioral and biochemical outcome measures in Rett syndrome rodent models$622,667
R01 · FY2016 · HD
Neurovisualization$340,835
U54 · FY2016 · HD
Clinical Translational$245,549
U54 · FY2016 · HD
Steps towards a paternal gene activation therapy for Angelman syndrome$236,024
U54 · FY2016 · HD
Neuroconnectivity Core$235,950
U54 · FY2016 · HD
The nature of astrocyte heterogeneity in RTT$196,974
R21 · FY2016 · NS
Administrative Core$131,044
U54 · FY2016 · HD
Neurobehavioral$109,061
U54 · FY2016 · HD
Neurovisualization$340,835
U54 · FY2015 · HD
Clinical Translational$245,549
U54 · FY2015 · HD
The nature of astrocyte heterogeneity in RTT$236,538
R21 · FY2015 · NS
Steps towards a paternal gene activation therapy for Angelman syndrome$236,024
U54 · FY2015 · HD
Neuroconnectivity Core$235,950
U54 · FY2015 · HD
Administrative Core$131,044
U54 · FY2015 · HD
Neurobehavioral$109,061
U54 · FY2015 · HD
Baylor Intellectual and Developmental Disabilities Research Centers$1,298,463
U54 · FY2014 · HD
Neurovisualization$340,835
U54 · FY2014 · HD
Clinical Translational$245,549
U54 · FY2014 · HD
Steps towards a paternal gene activation therapy for Angelman syndrome$236,024
U54 · FY2014 · HD
Neuroconnectivity Core$235,950
U54 · FY2014 · HD
Characterization of autonomic dysfunction in Rett syndrome & other MECP2 disorder$231,933
R01 · FY2014 · HD · contact PI
Administrative Core$131,044
U54 · FY2014 · HD
Characterization of autonomic dysfunction in Rett syndrome & other MECP2 disorder$121,608
R01 · FY2014 · HD · contact PI
Neurobehavioral$109,061
U54 · FY2014 · HD
Characterization of autonomic dysfunction in Rett syndrome & other MECP2 disorder$343,754
R01 · FY2013 · HD · contact PI
Characterizing autonomic dysfunction in Rett syndrome and other MECP2 disorders$362,228
R01 · FY2012 · HD · contact PI
Characterizing autonomic dysfunction in Rett syndrome and other MECP2 disorders$22,993
R01 · FY2012 · HD · contact PI
Characterization of autonomic dysfunction in Rett syndrome and other MECP2 disord$305,772
R01 · FY2011 · HD · contact PI
Characterization of autonomic dysfunction in Rett syndrome and other MECP2 disord$318,513
R01 · FY2010 · HD · contact PI
Analysis of the dopamine system in Rett syndrome$167,988
K08 · FY2009 · NS · contact PI
Analysis of the dopamine system in Rett syndrome$167,988
K08 · FY2008 · NS · contact PI
Analysis of the dopamine system in Rett syndrome$167,988
K08 · FY2007 · NS · contact PI
Analysis of the dopamine system in Rett syndrome$167,988
K08 · FY2006 · NS · contact PI
Analysis of the dopamine system in Rett syndrome$167,988
K08 · FY2005 · NS